We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current OCUL market cap is 893.25M. The company's latest EPS is USD -0.5432 and P/E is -11.30.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 11.97M | 14.08M | 13.37M | 15.19M | 15.08M |
| Operating Income | -21.55M | -19.36M | -22.55M | -20.57M | -19.21M |
| Net Income | -24.19M | -15.54M | -30.32M | -20.68M | -516k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 4.23M | 17.4M | 43.52M | 51.49M | 58.44M |
| Operating Income | -85.8M | -62.85M | -78.04M | -78.65M | -82.38M |
| Net Income | -86.37M | -155.64M | -6.55M | -71.04M | -80.74M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 158.58M | 149.29M | 128.57M | 122.56M | 162.38M |
| Total Liabilities | 112.35M | 113.91M | 118.86M | 119.47M | 154.53M |
| Total Equity | 46.23M | 35.38M | 9.71M | 3.09M | 7.85M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 78.74M | 261.86M | 204.89M | 149.29M | 252.06M |
| Total Liabilities | 82.37M | 185.77M | 116.89M | 113.91M | 160.93M |
| Total Equity | -3.63M | 76.1M | 88M | 35.38M | 91.13M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -42.65M | -59.6M | -19.97M | -40.05M | -47.78M |
| Investing | -1.57M | -3.72M | -3.38M | -5.37M | -5.63M |
| Financing | 996k | 1.45M | 78k | 9.72M | 61.66M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -77.58M | -53.55M | -64.55M | -59.6M | -70.23M |
| Investing | -2.24M | -841k | -1.19M | -3.72M | -6.09M |
| Financing | 75.34M | 228.01M | 2.85M | 1.45M | 169.83M |
| Market Cap | 893.25M |
| Price to Earnings Ratio | -11.30 |
| Price to Sales Ratio | 15.62 |
| Price to Cash Ratio | 4.66 |
| Price to Book Ratio | 10.01 |
| Dividend Yield | - |
| Shares Outstanding | 148.63M |
| Average Volume (1 week) | 1.21M |
| Average Volume (1 Month) | 1.4M |
| 52 Week Change | 3.09% |
| 52 Week High | 11.31 |
| 52 Week Low | 1.995 |
| Spread (Intraday) | 0.01 (0.17%) |
| Company Name | Ocular Therapeutix Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.ocutx.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
